Last reviewed · How we verify
NCT03155334
Understanding Evaluation of Patient Information Sheets by User Testing Method
NA trial testing PIS User Testing in MS (Multiple Sclerosis) in 100 participants. Status unknown.
20 February 2018
Quick facts
| Lead sponsor | Fondazione Italiana Sclerosi Multipla |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 100 |
| Start date | 31 January 2017 |
| Primary completion | 20 February 2018 |
| Estimated completion | 30 December 2018 |
| Sites | 2 locations across Italy, Romania |
Drugs / interventions tested
- PIS User Testing
Conditions studied
- MS (Multiple Sclerosis) — all drugs for MS (Multiple Sclerosis) →
Sponsor
Fondazione Italiana Sclerosi Multipla
Who can join
18 and older, any sex, with MS (Multiple Sclerosis). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this randomized, open label, crossover, single site study is to compare the PISs of two Multiple Sclerosis clinical trials to elucidate potential aspects of the given written information that could impact on the smooth running of the studies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03155334
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for MS (Multiple Sclerosis)
Currently open trials in the same condition.
- NCT07222618 — "Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS · recruiting
- NCT07087873 — Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiop · NA · recruiting
- NCT06999434 — Exploring the Utility of [18F]3F4AP for Demyelination Imaging · Phase 1 · recruiting
- NCT07235644 — Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Scle · active not recruiting
- NCT05857280 — EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (EXOSEP 2) · NA · recruiting
Other Fondazione Italiana Sclerosi Multipla trials
Trials by the same sponsor.
- NCT06805318 — Feasibility of a Vocational Rehabilitation Intervention for Job Retention in Workers With MS-RiaLSM Intervention Project · NA · recruiting
- NCT04011579 — Pilates Training in Multiple Sclerosis · NA · completed
- NCT05212805 — Promoting Aerobic Training in Multiple Sclerosis · NA · unknown
- NCT03608527 — Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis · NA · completed
- NCT04133779 — Observational Study on Multiple Sclerosis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03155334 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione Italiana Sclerosi Multipla
- Last refreshed: 16 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03155334.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing